Cargando…
Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment
Purpose: Global evidence-based treatment strategies for chronic obstructive pulmonary disease (COPD) recommend using long-acting bronchodilators (LABDs) as maintenance therapy. However, COPD patients are often undertreated. We examined COPD treatment patterns among Medicare beneficiaries who initiat...
Autores principales: | Celli, Bartolome R, Navaie, Maryam, Xu, Zhun, Cho-Reyes, Soojin, Dembek, Carole, Gilmer, Todd P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526678/ https://www.ncbi.nlm.nih.gov/pubmed/31190787 http://dx.doi.org/10.2147/COPD.S199251 |
Ejemplares similares
-
Inhaler device feature preferences among patients with obstructive lung diseases: A systematic review and meta-analysis
por: Navaie, Maryam, et al.
Publicado: (2020) -
Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis
por: Navaie, Maryam, et al.
Publicado: (2020) -
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
por: Ganapathy, Vaidyanathan, et al.
Publicado: (2017) -
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD
por: Bollu, Vamsi, et al.
Publicado: (2013) -
Role of arformoterol in the management of COPD
por: King, Paul
Publicado: (2008)